
PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial
Results of HPTN 082 - a randomized controlled trial offering PrEP to sexually active young women ages 16-25, following for 12 months. The participants were randomized to standard adherence support (counseling, 2-way SMS, adherence clubs) or enhanced adherence support (SOC + adherence feedback from intracellular TFV-DP levels in DBS). The study found high PrEP initiation, and over half of participants persisted through month 6. There was no statistical significance in adherence at 6 months between study arms. Participants were ineligible or discontinued treatment if they became pregnant.
Resource Details
- Study Type
- Randomized clinical trial (RCT)
- Year
- 2022
- Population
- Adolescent girls and young women
- Author
- Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, Pathak S, Mgodi N, Bekker LG, Donnell DJ, Wilson E, Yuha K, Anderson PL, Agyei Y, Noble H, Rose SM, Baeten JM, Fogel JM, Adeyeye A, Wiesner L, Rooney J, Delany-Moretlwe S.
More Publications & Resources


PrEP including LEN Counselling Guide for PBFP

LEN Learning Clinic 2: Clinical Considerations for the Implementation of LEN

Kenya Integrated Guidelines for Prevention, Treatment and Management of HIV, Sexually Transmitted Infections and Viral Hepatitis, 2026

Providing PrEP to Pregnant and Breastfeeding Women

Clinical Practice Guidelines for Providing PrEP for Pregnant and Breastfeeding Populations

Guidelines on Lenacapavir for HIV Prevention and Testing Strategies for Long-Acting Injectable Pre-Exposure Prophylaxis

PrEP and PEP Guidelines-Zambia

PrEP Lenacapavir Implementation Guidelines

Provider Training Toolkit on Use of Oral and Long-acting HIV PrEP: Lenacapavir-Focused Learning Pathway (Lessons 1-4)

Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP

Inclusion of Pregnant and Lactating People in the PURPOSE 1 Study: Efficacy, Safety, and Pharmacokinetics
No results found.
